Twelve Points Wealth Management LLC Gilead Sciences, Inc. Transaction History

Twelve Points Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	BUY	$59.54 - $68.01 $476 - $544	8 Added 0.13%	5,939 $366,000
Q2 2022 Jul 18, 2022	BUY	$57.72 - $65.01 $2,424 - $2,730	42 Added 0.71%	5,931 $367,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $56,819 - $71,200	-981 Reduced 14.28%	5,889 $350,000
Q4 2021 Mar 18, 2022	BUY	$64.88 - $73.64 $445,725 - $505,906	6,870 New	6,870 $499,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Twelve Points Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Twelve Points Wealth Management LLC with notifications on news.